ATE156359T1 - Phosphatdiester zur behandlung von proliferativen erkrankungen der epidermis - Google Patents

Phosphatdiester zur behandlung von proliferativen erkrankungen der epidermis

Info

Publication number
ATE156359T1
ATE156359T1 AT95302497T AT95302497T ATE156359T1 AT E156359 T1 ATE156359 T1 AT E156359T1 AT 95302497 T AT95302497 T AT 95302497T AT 95302497 T AT95302497 T AT 95302497T AT E156359 T1 ATE156359 T1 AT E156359T1
Authority
AT
Austria
Prior art keywords
epidermis
proliferative diseases
treatment
phosphate diester
chem
Prior art date
Application number
AT95302497T
Other languages
English (en)
Inventor
Kazumi Ogata
Rie Nagao
Takahiro Sakaue
Shinya Ogino
Sachiko Matsuura
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Application granted granted Critical
Publication of ATE156359T1 publication Critical patent/ATE156359T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT95302497T 1994-04-22 1995-04-13 Phosphatdiester zur behandlung von proliferativen erkrankungen der epidermis ATE156359T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8424894 1994-04-22

Publications (1)

Publication Number Publication Date
ATE156359T1 true ATE156359T1 (de) 1997-08-15

Family

ID=13825166

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95302497T ATE156359T1 (de) 1994-04-22 1995-04-13 Phosphatdiester zur behandlung von proliferativen erkrankungen der epidermis

Country Status (6)

Country Link
EP (1) EP0679399B1 (de)
KR (1) KR950031085A (de)
AT (1) ATE156359T1 (de)
DE (1) DE69500511T2 (de)
ES (1) ES2107279T3 (de)
TW (1) TW287103B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2209690A1 (en) * 1996-07-31 1998-01-31 Sachiko Matsuura Therapeutic drug for acne vulgaris
WO2002026238A1 (en) * 2000-09-26 2002-04-04 Vital Health Sciences Pty Ltd. Phosphate derivative supplements
AUPR549901A0 (en) * 2001-06-06 2001-07-12 Vital Health Sciences Pty Ltd Topical formulation containing tocopheryl phosphates
JP4745608B2 (ja) * 2001-07-27 2011-08-10 バイタル ヘルス サイエンシズ プロプライアタリー リミティド 電子伝達剤のリン酸誘導体を用いた皮膚治療
AU2002950713A0 (en) 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
US6645514B1 (en) 2002-12-19 2003-11-11 Access Business Group International, Llc Increasing skin cell renewal with water-soluble Vitamin E
WO2005084678A1 (en) 2004-03-03 2005-09-15 Vital Health Sciences Pty Ltd Alkaloid formulations
CA2611831C (en) * 2005-06-17 2014-09-16 Vital Health Sciences Pty Ltd. A carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
EP1973547A1 (de) * 2005-12-23 2008-10-01 Vital Health Sciences Pty Ltd. Verbindungen mit zytokin-modulierenden eigenschaften
US10071030B2 (en) 2010-02-05 2018-09-11 Phosphagenics Limited Carrier comprising non-neutralised tocopheryl phosphate
ES2829386T3 (es) 2010-03-30 2021-05-31 Phosphagenics Ltd Parche de administración transdérmica
EP2685992A4 (de) 2011-03-15 2014-09-10 Phosphagenics Ltd Aminochinoline als kinasehemmer
AU2016367708B2 (en) 2015-12-09 2022-07-14 Phosphagenics Limited Pharmaceutical formulation
MX2019006845A (es) 2016-12-21 2019-10-15 Avecho Biotechnology Ltd Proceso.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5659710A (en) * 1979-10-22 1981-05-23 Eisai Co Ltd Preventive and remedy for psoriasis
JPS62145019A (ja) * 1985-12-19 1987-06-29 Senjiyu Seiyaku Kk 抗炎症剤
US5122536A (en) * 1989-10-12 1992-06-16 Perricone Nicholas V Method for the topical treatment of psoriasis

Also Published As

Publication number Publication date
DE69500511D1 (de) 1997-09-11
DE69500511T2 (de) 1998-01-02
ES2107279T3 (es) 1997-11-16
EP0679399B1 (de) 1997-08-06
EP0679399A1 (de) 1995-11-02
KR950031085A (ko) 1995-12-18
TW287103B (de) 1996-10-01

Similar Documents

Publication Publication Date Title
DE69815527D1 (de) Verwendung von betulinsäure-derivaten zur behandlung und vorbeugung von melanomen
MX9302932A (es) Nuevas 4-aza-5&-androstan-3-onas 7b-substituidas como inhibidores de la5&-reductasa.
ATE156359T1 (de) Phosphatdiester zur behandlung von proliferativen erkrankungen der epidermis
ATE326956T1 (de) Verwendung von aminothiolverbindungen zur behandlung von nerven- und nieren-erkrankungen und der arzneimitteltoxizität
DE69334250D1 (de) Verfahren und Intermediate zur Herstellung von retroviralen Proteasehemmern
ATE280577T1 (de) Oxa-säuren und verwandte verbindungen zur behandlung von störungen der haut
ATE250576T1 (de) Substituierte pyrrolylverbindungen zur behandlung von entzündungen
ATE275383T1 (de) Oxadisäuren und verwandte verbindungen zur behandlung von hautstörungen
ATE207355T1 (de) Behandlung von hyperproliferativen gefässerkrankungen
ATE168007T1 (de) Zur behandlung von erkrankungen des zentralnervensystems verwendbare benzimidazole
ATE121939T1 (de) Ascorbinsäure-tocopheryl-phosphatdiester zur hemmung der maillard-reaktion.
ATE267180T1 (de) Phosphorderivate zur behandlung von aids
DE69707372D1 (de) Verwendung eines Phosphorsäurediesters zur Herstellung eines Arzneimittels zur Behandlung von Akne
DE69506197D1 (de) Verwendung eines Ascorbyl-tocopherylphosphats zur Herstellung eines Arzneimittels zur Behandlung der Pankreatitis
MX9203945A (es) Esteres bisfosfonicos de pirazolpirimidina y pirimidinilo como antiinflamatorios
DE69331171D1 (de) Chinolin und Chinazolin Derivate zur Behandlung von Arthritis
DE69501359D1 (de) Verwendung von Phosphatdiestern zur Behandlung von Erkrankungen der Retina
ATE101040T1 (de) Derivate und analoge von pyrimidon zur behandlung von asthma und bestimmte hautkrankheiten.
DE69116788D1 (de) 4-substituierte Dihydropyrido [4,3-d] pyrimidine als Analgetika und entzündungshemmende Mittel zur topischen Anwendung bei der Behandlung von Hauterkrankungen
DE60018200D1 (de) Verwendung von pleuromutilinderivaten zur transdermalen behandlung bakterieller erkrankungen
PT916666E (pt) 3-alquiloxi- ariloxi- ou arilalquiloxi-benzo¬b|tiofeno-2-carboxamidas como inibidores de adesao celular
DE69313261D1 (de) Verwendung von LACTOFERRIN zur Herstellung eines THERAPEUTISCHEN MITTELS zur Behandlung von RHEUMATISMUS
DE69419954D1 (de) Arzneimittel zur Behandlung von Hauterkrankungen
NO173991C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,2,5-ditiazocin-derivater
DE69619088D1 (de) Quinoxalin-Derivate zur Behandlung von Tinnitus

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties